Which peptides are in this family?
Best recorded finding for each peptide in this family
Each row grades one recorded finding, not the peptide or the medicine.
| Peptide | UK status | Finding | Evidence grade |
|---|---|---|---|
| Cagrilintide | Not licensed in the UK | Standalone Phase 2 weight trial | Moderate |
| Liraglutide | Licensed UK medicine | SCALE prediabetes progression trial | Moderate |
| Mazdutide | Not licensed in the UK | GLORY-1, phase 3 in China | Strong |
| Retatrutide | Not licensed in the UK | Phase 2 obesity trial | Moderate |
| Semaglutide | Licensed UK medicine | Weight change at 68 weeks | Strong |
| Survodutide | Not licensed in the UK | Phase 3 in obesity without diabetes | Strong |
| Tirzepatide | Licensed UK medicine | The SURMOUNT-1 obesity trial | Strong |
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.